Effects of Obesity Reduction on Cardiovascular Risk Factors: Comparison of Individual and Group Treatment - Substudy of the Croatian Healthy Weight Loss Programme

被引:0
|
作者
Jovanovic, Zeljko [3 ]
Crncevic-Orlic, Zeljka [2 ]
Stimac, Davor [2 ]
Kokic, Slaven [1 ]
Persic, Viktor [5 ]
Ruzic, Tatjana [4 ]
Goll-Baric, Sanda [3 ]
机构
[1] Univ Hosp Ctr Split, Clin Internal Med, Split 21000, Croatia
[2] Univ Hosp Ctr Rijeka, Rijeka, Croatia
[3] Healthy Weight Loss Project Rijeka, Rijeka, Croatia
[4] Psychiat Hosp Rab, Kampor, Croatia
[5] Thalasotherapia, Opatija, Croatia
关键词
cardiovascular diseases; obesity; orlistat; program evaluation; weight loss; DISEASE RISK; ORLISTAT;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
Prevention of obesity may help reduce the morbidity and mortality from cardiovascular diseases. In Croatia, over half of adult population is overweight. Aldo the basic medical principles of healthy weight-loss programmes are well known, it is believed that mainly because of the leak of successful therapeutic approach obesity remains the most challenging changeable cardiovascular risk factor in nowadays clinical practice. Objective of this Croatian Healthy Weight Loss Programme substudy was to determine effects and differences between the intensive group and intensive individual weight-loss program on weight loss and cardiovascular risk factor A clinical trial included 476 adults whose body mass index (BMI) was >30 or >28 accompanied by increased blood pressure, glucose, and cholesterol. The study participants completed either a group (n = 243) or individually-based (n = 233) 6-month weight-loss program consisting of education, low-fat diet, pharmacological treatment with orlistat, psychological counselling, and exercise. Body weight, body mass index, blood pressure, blood sugar and blood cholesterol were measured in all participants after 3 and 6 months. The average weight loss was 12.2 (13%) kg and 7.6 (9%) kg in the group and individual program, respectively. Beside the weight reduction, the levels of blood cholesterol, glucose, and blood pressure were also significantly reduced in comparison with baseline, decreasing to normal values in all participants (P<0.001 for all). Decrease in the monitored parameters was greater in participants in the group program. The weight loss program provided a healthy loss of extra weight in the period of 6 months. The group program produced greater decrease in body weight, body mass index, blood pressure, glucose, and cholesterol than the individual program.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 43 条
  • [41] Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery
    de Luis, D. A.
    Gonzalez Sagrado, M.
    Pacheco, D.
    Terroba, M. C.
    Martin, T.
    Cuellar, L.
    Ventosa, M.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2010, 6 (05) : 516 - 520
  • [42] Cashew nut (Anacardium occidentale L.) and cashew nut oil reduce cardiovascular risk factors in adults on weight-loss treatment: a randomized controlled three-arm trial (Brazilian Nuts Study)
    Meneguelli, Talitha Silva
    Kravchychyn, Ana Claudia Pelissari
    Wendling, Aline Lage
    Dionisio, Ana Paula
    Bressan, Josefina
    Martino, Hercia Stampini Duarte
    Tako, Elad
    Hermsdorff, Helen Hermana Miranda
    FRONTIERS IN NUTRITION, 2024, 11
  • [43] Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2
    Antonio de Luis, Daniel
    Ovalle, Hilda F.
    Diaz Soto, Gonzalo
    Izaola, Olatz
    de la Fuente, Beatriz
    Romero, Enrique
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 324 - 327